## 2026-09-11T01:47:22Z
You are the Benchmark & Test Explorer for Phase 22.
Your working directory is: d:\Finance\code\stock\.agents\explorer_quant_phase22_benchmark
Please create your progress.md and update it as you work.

MANDATORY FIRST STEP:
Read d:\Finance\code\stock\.agents\ORIGINAL_REQUEST.md, especially section ## 2026-09-11T01:45:34Z and ## 2026-09-10T01:13:45Z.

Scope & Mission:
Investigate existing benchmark scripts, test suites, reports, and documentation:
- trading_system/scripts/benchmark_phase21_quant_performance.py (and phase20 if helpful)
- tests/test_phase21_quant_performance.py
- reports/quant_benchmark_comparison_phase21.md and trading_system/result/quant_benchmark_comparison_phase21.md
- AGENTS.md

Specifically analyze:
1. How Phase 21 benchmark script operates: data generation/simulation across 5 markets (KOSPI, KOSDAQ, S&P 500, NASDAQ, RUSSELL 2000), calculation of 15 key metrics, comparison with previous phases (Phase 21 vs Phase 20 vs Phase 19 etc.).
2. How the 3 comparison tables are formatted: [표 1] 15대 종합 지표 비교표, [표 2] 5대 시장별 성과표, [표 3] 전략 팩터 기여도표.
3. Target acceptance criteria for Phase 22:
   - Net Expected Return: >= 111.15% (Phase 21 baseline: 109.06%)
   - Annualized Sharpe Ratio: >= 16.55 (Phase 21 baseline: 15.98)
   - Maximum Drawdown (MDD): <= -0.024% (Phase 21 baseline: -0.028%)
   - Trading & Friction Costs: <= 0.038 bps (Phase 21 baseline: 0.052 bps)
   - Execution Slippage: <= 0.002 bps (Phase 21 baseline: 0.003 bps)
   - Top-Decile Alpha Spread: >= 82.5% (Phase 21 baseline: 80.2%)
4. Structure of tests/test_phase22_*.py and AGENTS.md update requirements (Key Files table, Requirements History R38).
5. Write a comprehensive, step-by-step implementation guide in d:\Finance\code\stock\.agents\explorer_quant_phase22_benchmark\handoff.md.
Communicate back via send_message when your handoff.md is ready.
Do NOT modify source code files directly (read-only investigation).
